Psilocybin mushroom. Psilocybin mushrooms, also known as psychedelic mushrooms, are mushrooms that contain the psychedelic drugs psilocybin and psilocin. Common colloquial terms include magic mushrooms and shrooms.[1] Biological genera containing psilocybin mushrooms include Copelandia, Galerina, Gymnopilus, Inocybe, Mycena, Panaeolus, Pholiotina, Pluteus, and Psilocybe. About 40 species are found in the genus Psilocybe. Psilocybe cubensis is the most common psilocybin mushroom in subtropical areas and the black market. Psilocybin mushrooms have likely been used since prehistoric times and may have been depicted in rock art. History[edit] Early[edit] Archaeological evidence indicates the use of psilocybin-containing mushrooms in ancient times. Hallucinogenic species of the psilocybe genus have a history of use among the native peoples of Mesoamerica for religious communion, divination, and healing, from pre-Columbian times to the present day.
Modern[edit] Occurrence[edit] Effects[edit] Sensory[edit] Alexander Shulgin. Alexander "Sasha" Theodore Shulgin[2] (born June 17, 1925) is an American medicinal chemist, biochemist, pharmacologist, psychopharmacologist, and author. Shulgin is credited with introducing MDMA ("ecstasy") to psychologists in the late 1970s for psychopharmaceutical use. He discovered, synthesized, and personally bioassayed over 230 psychoactive compounds, and evaluated them for their psychedelic and/or entactogenic potential. Due in part to Shulgin's extensive work in the field of psychedelic research and the rational drug design of psychedelic drugs, he has since been dubbed the "godfather of psychedelics".[3] Life and career[edit] Shulgin was born in Berkeley, California to Theodore Stevens Shulgin (1893–1978)[4] and Henrietta D.
(née Aten) Shulgin (1888–1960).[5][6] His father was born in Russia, while his mother was born in Illinois. Shulgin began studying organic chemistry as a Harvard University scholarship student at the age of 16. He lives in Lafayette, California. Books[edit] 2C-I. Recreational use[edit] In the early 2000s, 2C-I was sold in Dutch smart shops after the drug 2C-B was banned.[5] In April 2008, 2C-I was also banned in the Netherlands, along with three other 2C-x phenethylamines previously sold in Dutch smartshops for short periods of time.
During the same period, 2C-I also became available in powder form from several online vendors of research chemicals in the United States, Asia, and Western Europe. Effects[edit] The onset of effects usually occurs within two hours, and the effects of the drug typically last somewhere in the range of 4 to 12 hours (depending on the dose). The effects of the drug at small dosages (less than 12 mg) has been reported as more mental and less sensory than those of 2C-B. Dosage[edit] The lethal dosage is unknown. Degradation[edit] 2c-i has been reported by users to degrade with elevated temperatures. Drug prohibition laws[edit] European Union[edit] Denmark[edit] Controlled substance.[9] Germany[edit] Greece[edit] Ireland[edit] 25I-NBOMe - One Bad Trip From An Experienced User - 97404.
Citation: Fluorite. "One Bad Trip From An Experienced User: An Experience with 25I-NBOMe (ID 97404)". Erowid.org. Nov 26, 2012. erowid.org/exp/97404 Prior to my experience with 25-I, I should say that I had very limited experience with LSD and DMT. I had used 25-I many times recreationally for the past few months. The experience that I am about to describe is the reason why I refuse to take 25-I ever again. My fiancé and I at the time had decided to drop two blotter tabs of 25-I and take a nice little nature walk on a local walk-way in our city. We started walking along the path and came upon one of the local parks that sits on the path. At this point, our visuals are getting really fucking intense. But I didn’t want to go home.
Somehow, we manage to cross the street (which in all honesty, I have no idea how we did it safely) and make it back to the gazebo area in the park to wait for two of our friends to pick us up and take us back home. Psychoactive drug. An assortment of psychoactive drugs—street drugs and medications: Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g. euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing.
Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences – when used consistently in excess. In addition, sustained use of some substances may produce a physical dependence or psychological dependence syndrome associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation aims to break this cycle of dependency, through a combination of psychotherapy, support groups, maintenance and even other psychoactive substances.
History[edit] Alcohol is a widely used and abused psychoactive drug. Uses[edit]